Filing metadata

Accession number
0001104659-20-065389
Form type
Form 4
Filer
RVL Pharmaceuticals plc
CIK
CIK 1739426
Filed
May 22, 2020
Reporting period
May 20, 2020
Description
Insider transaction

Explore SEC Filings Hub